Klinische Wochenschrift

, Volume 56, Issue 16, pp 819–823 | Cite as

Treatment of hereditary angioedema

  • Bianca Marasini
  • M. Cicardi
  • G. C. Martignoni
  • A. Agostoni
Originalien

Summary

The purpose of this study was to report the results of different treatments in 20 patients with hereditary angioedema. Effectiveness of tranexamic acid in preventing swellings was evaluated in 15 patients: in all but 3 subjects tranexamic acid was effective without serious side effects. 15 severe attacks of edema were managed with intravenous infusions of either kallikrein inhibitor (8 cases) or concentrate of C 1 esterase inhibitor (7 cases). In only 1 case was the kallikrein inhibitor unsuccessful. C 1 esterase inhibitor concentrate proved highly effective in the treatment of acute attacks (the result was lacking in one patient because of too low dosage of the drug). No side effects were observed with both treatments, but improvement was more rapidly achieved with infusion of C 1 esterase inhibitor. The serum levels of C 4 and C 1 esterase inhibitor and the activity of C 1 esterase inhibitor before and after long-term prophylaxis and acute attacks treatment were investigated.

Key words

Hereditary angioedema Tranexamic acid C 1 esterase inhibitor Kallikrein inhibitor 

Therapie des hereditären angioneurotischen Ödems

Zusammenfassung

In der vorliegenden Studie wird über die Ergebnisse verschiedener Behandlungsverfahren bei 20 Patienten mit hereditärem angioneurotischem Ödem berichtet. Die Wirksamkeit des Esterase-Inhibitors Trancxam-Säure zur Verhütung des Ödems wurde bei 15 Patienten erprobt. Bei 12 der 15 Patienten war Trancxam-Säure wirksam und ohne wesentliche Nebenwirkungen. 15 schwere Anfälle von angioneurotischem Ödem wurden behandelt mit intravenösen Infusionen entweder von Kallikrein-Inhibitor (8 Fälle) oder einem Konzentrat eines C1-Esterase-Inhibitors (7 Fälle). Nach dem Kallikrein-Inhibitor blieb nur in 1 Fall ein Erfolg aus. Das Konzentrat von C 1-Esterase-Inhibitor zeigte sich äußerst wirksam in der Behandlung akuter Anfälle (1 Mißerfolg infolge zu geringer Dosierung). Nebenwirkungen wurden bei beiden Behandlungsverfahren nicht beobachtet, jedoch konnte die Besserung mit Hilfe des C 1-Esterase-Inhibitors schneller erreicht werden. Die Serumspiegel von C 4- und C 1-Esterase-Inhibitor und die Aktivität von C 1-Esterase-Inhibitor vor und nach Langzeitprophylaxe und nach Therapie akuter Anfälle wurden untersucht.

Schlüsselwörter

Hereditäres angioneurotisches Ödem Trancxam-Säure C 1-Esterase-Inhibitor Kallikrein-Inhibitor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Agostoni, A., Marasini, B., Cicardi, M., Martignoni, G.C., Brenna, O.: Studio mediante dosaggio enzimatico e immunochimico dell'inibitore della C 1 esterasi in 59 pazienti affeti da angioedema ereditario. Bollettino Istituto Sieroterapico Milanese,56, 22 (1977)Google Scholar
  2. 2.
    Agostoni, A., Marasini, B., Martignoni, G.C., Cicardi, M.: Hereditary angioneurotic oedema. Klin. Wschr.53, 679 (1975)Google Scholar
  3. 3.
    Agostoni, A., Martignoni, G.C.: Hereditary angioneurotic oedema. Lancetii, 325 (1973)Google Scholar
  4. 4.
    Brackertz, D., Kueppers, F.: Hereditary angioneurotic oedema. Lancetii, 680 (1973)Google Scholar
  5. 5.
    Davies, D., Howell, D.A.: Tranexamic acid and arterial thrombosis. Lanceti, 49 (1977)Google Scholar
  6. 6.
    Donaldson, V.H., Evans, R.R.: A biochemical abnormality in hereditary angioneurotic oedema: absence of serum inhibitor of C 1 esterase. Amer. J. Med.35, 37 (1963)Google Scholar
  7. 7.
    Donaldson, V.H., Merler, E., Rosen, F.S., Kretschmer, K.W., Lepow, I.H.: A polypeptide kinin in hereditary angioneurotic oedema plasma: role of complement in its formation. J. Lab. Clin. Med.76, 986 (1970)Google Scholar
  8. 8.
    Fine, S.R., Fogarty, M., Linz, A.: Fresh frozen plasma for prophylaxis in hereditary angioedema. J. All. Clin. Immunol.57, 624 (1976)Google Scholar
  9. 9.
    Frank, M.M., Gelfand, J.A., Atkinson, J.P.: Hereditary angioedema: the clinical syndrome and its management. Ann. Int. Med.84, 580 (1976)Google Scholar
  10. 10.
    Frank, M.M., Sergent, J.S., Kane, M.A., Alling, D.W.: Epsilon aminocaproic acid therapy of hereditary angioedema. New Engl. J. Med.286, 808 (1972)Google Scholar
  11. 11.
    Gelfand, J.A., Sherins, R.J., Alling, D.W., Frank, M.M.: Treatment of hereditary angioedema with Danazol. Reversal of clinical and biochemical abnormalities. New Engl. J. Med.295, 1444 (1976)Google Scholar
  12. 12.
    Jaffe, C.J., Atkinson, J.P., Gelfand, J.A.: Hereditary angioedema. The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J. All. Clin. Immunol.55, 386 (1975)Google Scholar
  13. 13.
    Johns, M.E., Vanselow, N.A., Boles, R., Arbor, A.: Hereditary angioneurotic oedema, treatment with epsilon aminocaproic acid during surgery. Arch. Otolaryng.99, 388 (1974)Google Scholar
  14. 14.
    Juhlin, L., Michaelson, G.: Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm.-Venereol.49, 37 (1969)Google Scholar
  15. 15.
    Klemperer, M.R., Rosen, F.S., Donaldson, V.H.: A polypeptide derived from the second component of human complement (C 2) which increases vascular permeability. J. Clin. Invest.48, 44 (abs.) (1969)Google Scholar
  16. 16.
    Lachmann, P.J., Hobart, M.J., Aston, W.P.: Complement technology. In: “Handbook of experimental immunology” D.M. Weir ed., Oxford: Blackwell 1973, pp. 1–17Google Scholar
  17. 17.
    Landermann, N.S.: Hereditary angioneurotic edema. Case report and review of the literature. J. All.33, 316 (1962)Google Scholar
  18. 18.
    Lundh, B., Laurell, A.B., Wetterquist, H., White, T., Granerus, G.: A case of hereditary angioneurotic oedema successfully treated with epsilon aminocaproic acid. Studies on C 1 esterase inhibitor, C 1 activation, plasminogen level and histamine metabolism. Clin. Exp. Immunol.3, 733 (1968)Google Scholar
  19. 19.
    Pence, R.L., Evans, R., Guernsey, L.H., Gerhard, R.C.: Prophylactic use of epsilon aminocaproic acid for oral surgery in a patient with hereditary angioneurotic edema. J. All. Clin. Immunol.53, 298 (1974)Google Scholar
  20. 20.
    Pickering, R.J., Kelly, J.R., Good, R.A., Gevurz, H.: Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lanceti, 326 (1969)Google Scholar
  21. 21.
    Proud, G., Chamberlain, J.: Anaphylactic reaction to aprotinin. Lancetii, 48 (1976)Google Scholar
  22. 22.
    Rosen, F.S., Austen, K.F.: Androgen therapy in hereditary angioneurotic edema. New Engl. J. Med.295, 1476 (1976)Google Scholar
  23. 23.
    Rosen, F.S., Charache, P., Pensky, J., Donaldson, V.H.: Hereditary angioneurotic edema: two genetic variants. Science148, 957 (1965)Google Scholar
  24. 24.
    Ross, W.F., Logue, G.L., Silbermann, H.R.: The effect of synthetic androgens on clinical course and C 1 esterase inhibitor (C 1-INH) levels in hereditary angioneurotic edema (HANE). Clin. Res.24, 482 (abs.). (1976)Google Scholar
  25. 25.
    Sjolm, I., Wiman, B., Wallen, P.: Studies on conformational changes of plasminogen induced during activation to plasmin and by 6-aminoexanoic acid. Eur. J. Biochem.39, 471 (1973)Google Scholar
  26. 26.
    Soter, N.A., Austen, K.F., Gigli, I.: Inhibition by epsilon aminocaproic acid of the activation of the first component of the complement system. J. Immunol.114, 928 (1975)Google Scholar
  27. 27.
    Violand, B.N., Sodetz, J.M., Castellino, F.J.: The effect of aminocaproic acid on the gross conformation of plasminogen and plasmin. Arch. Biochem. Biophys.170, 300 (1975)Google Scholar
  28. 28.
    Vogelaar, E.F., Brummelhuis, H.G.J., Krunen, H.W.: Contribution to the optimal use of human blood. Vox Sang.26, 118 (1974)Google Scholar
  29. 29.
    Zachariae, H., Laurberg, G., Hjortshoj, A.: Tranexamic acid (Cyklokapron) in hereditary angioneurotic edema. Ugeskrift for Laege137, 1106 (1975)Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • Bianca Marasini
    • 1
  • M. Cicardi
    • 1
  • G. C. Martignoni
    • 1
  • A. Agostoni
    • 1
  1. 1.3° Cattedra di Patologia Speciale Medica dell'UniversitàMilanoItalia

Personalised recommendations